Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    Open Studies | "Gastritis"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Gastritis" (53 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Not yet recruiting Linked Color Imaging/Magnifying Blue Laser Imaging to Differentiate H. Pylori Associated Gastritis and Gastric Atrophy
Conditions: Gastritis;   Helicobacter Pylori Associated Gastritis;   Atrophic Gastritis
Intervention: Device: Digital chromoendoscopy and magnification
2 Recruiting Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
Conditions: Helicobacter Pylori Infection;   Atrophic Gastritis;   Intestinal Metaplasia
Intervention:
3 Recruiting Randomized, Placebo-Controlled, Phase 3 Trial of BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis (The GUARD Study)
Conditions: Gastroenteritis;   Gastritis
Intervention: Drug: RHB-102
4 Recruiting Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Condition: Gastritis
Interventions: Drug: GC6101A 37.5mg;   Drug: GC6101A 75mg;   Drug: GC6101A 150mg;   Drug: Placebo
5 Recruiting Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort
Conditions: Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Gastroenteritis;   Eosinophilic Colitis
Intervention:
6 Unknown  Esomeprazole Treatment for Patients With Lymphocytic Gastritis
Condition: Lymphocytic Gastritis
Intervention: Drug: Esomeprazole
7 Unknown  A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034
Conditions: Acute Gastritis;   Chronic Gastritis
Interventions: Drug: DA-6034;   Drug: Rebamipide 300mg
8 Recruiting Usefulness of Serum Pepsinogen and Gastrin as the Predictive Biomarker of Atrophic Gastritis, Intestinal Metaplasia and Gastric Cancer in Korea
Condition: Atrophic Gastritis
Intervention: Drug: pepsinogen and gastrin
9 Not yet recruiting Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia
Conditions: Chronic Atrophic Gastritis;   Intestinal Metaplasia of Gastric Mucosa
Interventions: Drug: Curcumin;   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment
10 Recruiting OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages
Conditions: Eosinophilic Gastrointestinal Disorders (EGIDs);   Eosinophilic Esophagitis;   Eosinophilic Gastritis;   Eosinophilic Colitis
Intervention:
11 Not yet recruiting System Biology of Spleen Deficiency Syndrome
Conditions: Gastritis, Atrophic;   Gastric Cancer
Intervention:
12 Recruiting Gastric Cancer Screening Quality Improvement System Establishment
Conditions: Gastric Cancer;   Gastritis, Atrophic;   Intestinal Metaplasia
Intervention: Behavioral: Education and feedback
13 Unknown  The Metabolic Contribution of the Human Microbiota to Resting Energy Expenditure
Condition: Gastritis
Intervention: Procedure: Resting Energy Expenditure examination
14 Recruiting Volatile Markers in Digestive Cancer
Conditions: Colorectal Cancer;   Colorectal Adenoma;   Gastric Cancer;   Peptic Ulcer Disease;   Atrophic Gastritis;   Intestinal Metaplasia;   H.Pylori Infection;   Normal Control;   Average-risk General Population
Interventions: Procedure: Breath sampling for volatile marker detection;   Procedure: Upper endoscopy with biopsies;   Procedure: Colonoscopy with biopsies or lesion removal when required;   Procedure: Plasma/serum sampling;   Procedure: Faecal sample acquisition;   Procedure: Histological evaluation of the surgery material
15 Recruiting Effect of ALBIS on Gastroduodenal Mucosal Injury in Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Conditions: Gastritis;   Gastroduodenal Ulcer
Interventions: Drug: ALBIS;   Drug: Placebo
16 Unknown  The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy
Conditions: Helicobacter Pylori Infection;   Peptic Ulcer;   Bile Reflux;   Gastritis
Intervention:
17 Not yet recruiting Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
Condition: Acute and Chronic Gastric Inflammation Patients
Interventions: Drug: DW-3101_150mg;   Drug: DW-3101_300mg;   Drug: DW-3101_600mg;   Drug: Placebo
18 Unknown  Gastropanel for Gastric Atrophy and Cancer Risk Assessment
Conditions: Gastritis, Atrophic;   Stomach Neoplasms
Interventions: Procedure: GastroPanel test;   Procedure: Gastroscopy
19 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
20 Recruiting A Relevance Study Between the Result of Clinical Drug Intervention and Next-generation Sequencing Technology Focused on Refractory Helicobacter Pylori Infection
Condition: Gastritis
Interventions: Device: The eradication times of the patients;   Device: The result of 13C-urea breath test after treatment

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years